Vermont Drug and Alcohol Inpatient Treatment Licensing

Author: A. Ant, CADC-II, Licensing & Accreditation Expert

Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.

Apply now: DAIL Therapeutic Community Residence License Application | Questions: (802) 241-0480

Residential substance use disorder treatment in Vermont touches two state offices, and the first planning question is whether you need one or both. The Department of Disabilities, Aging and Independent Living (DAIL), Division of Licensing and Protection (DLP) licenses the residence itself as a Therapeutic Community Residence. The Department of Health’s Division of Substance Use Programs (DSU) certifies treatment programs, and its rule makes that certification mandatory for any program receiving state or federal funding from the Department. Reading the two rules together, we take this to mean a program planning to take Department grants or contracts needs both, and neither one stands in for the other. No single rule says so in one place, so treat that as our interpretation.

The Therapeutic Community Residence License Covers More Than SUD

The license category turns on the kind of care, not on a diagnosis. 33 V.S.A. § 7102 defines a therapeutic community residence as a place, other than a hospital, that provides “transitional individualized treatment to three or more residents with major life adjustment problems, such as a substance use disorder, psychiatric disability, or delinquency.” Section 7103 then says a person “shall not operate” one “without first obtaining a license.” Because substance use and psychiatric populations sit in the same definition, a co-occurring program is licensed under one rule rather than two.

The operating standards are the Licensing and Operating Regulations for Therapeutic Community Residences (the Cornell Legal Information Institute copy of the rule numbers it Code Vt. R. 13-110-012). DLP’s own survey reports cite the version “effective 3/1/22.” DAIL proposed an amendment in 2024, mainly to add emergency involuntary procedure rules for secure residential recovery facilities, and the Legislative Committee on Administrative Rules approved it (file 24-P35) on January 30, 2025. We could not find a final adoption notice or effective date for that amendment, so we work from the 2022 text and suggest you ask DLP which version your survey will use. Licenses are issued for one year. The application form is shared with Assisted Living Residences, Homes for the Terminally Ill and Residential Care Homes, so mark the Therapeutic Community Residence box.

DSU Certification Is a Separate Track, Not a Formality

A building license and a treatment certification answer different questions. The DLP license lets you operate the residence. It does not make you a certified SUD treatment provider. DSU certification comes from the Department of Health’s Substance Use Disorder Treatment Certification Rule (effective January 1, 2020), which applies to “any substance use disorder treatment program that receives state or federal funding from the Department.” A certified program that also holds a Department contract or grant is what the rule calls a Preferred Provider. Certificates run for up to three years, with renewal paperwork owed to DSU 60 or more days ahead of expiration. Before any certificate issues, DSU’s treatment standards call for a visit to each service location, separate from DLP’s survey. Neither the rule nor the standards mention CARF, The Joint Commission or deemed status, so as we read them, national accreditation does not take the place of the DSU review.

Levels of Care in DSU’s Treatment Standards

DSU’s Preferred Provider treatment standards describe residential care as “an organized service in alignment with ASAM Criteria 3rd edition 3.1 to 3.7 level of care” with 24-hour supervision. Each level has its own section: 3.1 clinically managed low-intensity residential, 3.3 and 3.5 clinically managed high-intensity residential, 3.7 medically monitored intensive inpatient, and two withdrawal management levels, 3.2-WM (clinically managed residential) and 3.7-WM (medically monitored inpatient). The 3.7-WM section, for example, calls for physicians or physician extenders available by phone 24 hours a day and a registered nurse or other licensed and credentialed nurse to do the nursing assessment on admission. Build your program description around the 3rd edition language these standards use, since that is what the site visit checks.

CARF’s ASAM Level of Care Certification is a different credential altogether. It is a national certification delivered by CARF in partnership with ASAM and currently available for adult residential Levels 3.1, 3.5 and 3.7, and certified programs show up in CARF’s provider search under the “ASAM Level of Care 3.7” filter. Vermont’s DSU rule and standards do not reference it, so it does not replace a TCR license or DSU certification. What it gives a Vermont 3.7 program is an outside check on its capacity to deliver that level, one a payer or referral source can look up without asking the state. It does not cover Vermont’s 3.3 level or either withdrawal management level.

Hospital-Based Withdrawal Management

A 3.7-WM unit inside a hospital is a different licensing picture. The TCR definition excludes hospitals, and hospitals are licensed by the State Board of Health under the Hospital Licensing Rule (effective June 1, 2022), which names the Board as “the licensing agency per 18 V.S.A. Ch. 43.” Hospital licenses expire every December 31, and a hospital holding deemed status from a CMS-approved accreditor such as The Joint Commission is treated as meeting the federal Conditions of Participation. If that hospital unit takes DSU funding for withdrawal management, the DSU certification rule applies to it as well.

Certificate of Need Genuinely Applies Here

The Green Mountain Care Board (GMCB) runs Certificate of Need review under 18 V.S.A. §§ 9431 to 9446, and it has used that authority on SUD residential care. In May 2023 it approved an emergency CON for the purchase of the company operating Sana at Stowe, which the decision describes as “a 32-bed substance use disorder (SUD) treatment facility.”

The dollar triggers moved recently. Act 15 of 2025, signed May 13, 2025 and effective on passage for projects started on or after that date, set the thresholds at $10 million in capital spending, $5 million for a single piece of diagnostic and therapeutic equipment, and $3 million in annual operating expense for a new health care service, and the statute now uses those same figures for hospitals and every other health care facility. Under § 9434(e) GMCB can adjust them for inflation. Its 2026 CON Bulletin 004, dated February 1, 2026, carries the adjusted numbers, but we could not open it, so ask GMCB for the current amounts before relying on them. A project starts with a Letter of Intent, or a Request for Jurisdictional Determination if you are unsure CON applies, sent to gmcb.con@vermont.gov. The fee is 0.125% of project costs, with a $250 minimum and a $20,000 cap.

Two exclusions in 18 V.S.A. § 9435 are worth checking early. A facility where prescribing, dispensing or administering medication for opioid use disorder is a principal activity is excluded with the Commissioner of Health’s approval, and a project funded in whole or substantial part by a State contract or grant is excluded as long as the State agency sponsoring the project or awarding the grant informs GMCB. GMCB also granted BAART’s proposed opioid treatment hub in Bennington an exemption from CON review in February 2024. Run your capital and operating numbers against these thresholds before you sign a lease or set a construction budget.

Medication-Assisted Treatment

The federal X-waiver is gone. DEA’s January 2023 letter to registrants says “a DATA-Waiver registration is no longer required” and that buprenorphine prescriptions “only require a standard DEA registration number,” with no patient caps, so a residential program can offer buprenorphine through its own prescriber. Vermont adds its own layer: the Department of Health’s Rules Governing Medications for Opioid Use Disorder (effective May 15, 2024) cover office-based opioid treatment (OBOT) providers and opioid treatment programs (OTPs), and DSU’s standards require Preferred Providers that administer MOUD to follow the Department’s MOUD rules. An OTP also needs a current certification from the Secretary of HHS under 42 CFR 8.11, and the federal rule says OTPs “shall comply with all pertinent Federal and State laws and regulations.”

Ongoing opioid treatment in Vermont is organized as Hub and Spoke. The Blueprint for Health describes nine regional Hubs and more than 87 Spokes, notes that patients “may move back and forth between Hub & Spokes as their needs change,” and says the State pays for these services through Medicaid. In our view a residential program treating opioid use disorder should have a written coordination agreement with its regional Hub before it opens, so residents on methadone or buprenorphine keep their dosing and have somewhere to step down to at discharge.

Ketamine for Co-occurring Depression in a Vermont Residential Program

Neither DSU’s certification rule nor its treatment standards mention ketamine. What follows reads the medication and level-of-care provisions DSU does have, together with federal drug rules, so treat the fit as our interpretation and confirm it with DSU before the first dose.

DSU gives a certified residential program fewer specific hooks for this than most states do, and that cuts both ways. Section 11.1 of the Preferred Provider standards says a provider is authorized to deliver “only the specific levels of care and associated services, at specific sites, approved and certified by DSU.” The medication sections are general: medications are given “in accordance with accepted and statutory clinical practice,” the program keeps a list of clinical staff authorized “by the Preferred Provider and by law to administer or dispense medications,” and self-administration is permitted “only when specifically ordered” (sections 18.1 to 18.3). There is no ketamine service to apply for. The question to put to DSU in writing is whether a ketamine series for a resident’s depression is one of the associated services your certificate already covers or something it has to approve. We didn’t find a notice or approval step in the standards for adding a service, which is exactly why the answer should come from DSU in an email before launch.

The level of care you hold matters more than the paperwork. A 3.7-WM program already has physicians or physician extenders “available 24 hours a day by phone” and a nurse responsible for overseeing medication administration on an hourly basis if needed (section 23.1.3), which is the kind of coverage a patient in a dissociative state needs. A 3.1 house whose medical backup is phone or in-person consultation with a physician (section 24.1.1.1) is a poor place for infusions, and we would keep ketamine out of it.

Federal rules don’t change for a residential setting. Ketamine is a Schedule III controlled substance (21 CFR 1308.13(c)(7)), and 21 CFR 1301.12 requires a separate DEA registration for each place where controlled substances are administered or dispensed, so a prescriber’s registration at another office doesn’t cover a residence that keeps a supply. Ketamine has no FDA approval for any substance use disorder, which means it isn’t medication for opioid use disorder and has no place in the Hub coordination plan described above. Esketamine (Spravato) is its own case: the FDA labeling makes it available only through a restricted REMS program, only in REMS-certified healthcare settings, with monitoring for at least 2 hours after each dose.

The Vermont Prescription Monitoring System rule, in its July 2017 version (the newest we could find), exempts “a drug administered directly to a patient” from reporting (section 4.5.1). Its section 6.2 query triggers are mostly about opioids, benzodiazepines and buprenorphine, although 6.2.3 also calls for a query before any replacement prescription for a Schedule II to IV drug. A take-home prescription is a different matter, because prescribers who dispense Schedule III drugs report under section 4.4. We found no Vermont Board of Nursing position on nurses giving ketamine, so nursing scope here runs through the program’s own policies and the prescriber’s orders. A nurse practitioner with fewer than 24 months and 2,400 hours of practice in their role needs a formal agreement with a collaborating provider under 26 V.S.A. § 1613.

Handing Off at Discharge

Staff who can watch the hours after each session make a residential stay a reasonable place to start, but most series outlast the stay. Continuing usually means an outpatient ketamine clinic. Vermont’s professional corporation statute (11 V.S.A. chapter 3) lets licensed people incorporate and limits shares to licensees, yet nothing we read forces a physician practice into that form, and Act 133 of 2026, which reins in private equity control of health care facilities, is the newer wrinkle. Both are covered in the ketamine section of Vermont Drug and Alcohol Outpatient Treatment Licensing. If the residential program and the clinic share owners or exchange money, have counsel look at the referral flow under the federal Eliminating Kickbacks in Recovery Act (18 U.S.C. § 220), which covers remuneration for referrals to a “clinical treatment facility,” a term that includes residential SUD treatment licensed or certified under state law.

Staffing a Residential Program

Vermont’s tiered addiction credentials are the real lever on residential staffing costs. A residential program needs a clinical director, nursing coverage matched to acuity, and trained direct-care staff around the clock. The TCR regulations require “at least one (1) staff member on duty and in charge at all times,” and DSU’s standards build 24-hour supervision into the definition of residential care. BLS OEWS data for May 2025 puts the statewide median for Vermont’s substance abuse, behavioral disorder, and mental health counselors at roughly $60,410 a year, slightly above the $59,350 national median. Add a clinical director and round-the-clock coverage to several counselors and payroll commonly runs past $380,000 a year, before nursing and medical costs. Small state, real number, and Vermont’s counselor tiers give you somewhere to work from. The Office of Professional Regulation (OPR) issues three addiction credentials: Licensed Alcohol and Drug Counselor (LADC), certified Alcohol and Drug Abuse Counselor (ADC), and Apprentice Addiction Professional (AAP). Under 26 V.S.A. § 3236 an LADC needs a master’s or doctorate in a human services field, an OPR or IC&RC counselor certification, a passing exam score and 2,000 hours of supervised practice. OPR’s application instructions fill in the lower tiers. An AAP applicant must have finished, or be enrolled in, a course of study toward at least an associate degree, complete 40 hours of substance abuse education within the five years before applying, work for a preferred provider and pass the exam. An ADC applicant on the exam route needs a bachelor’s degree or higher, 270 hours of substance use disorder education, employment with an ADAP certified provider and 4,000 hours of supervision, one hour for every 40 hours of practice. In a DSU-certified program, each counselor must be licensed, hold an ADC certificate, obtain an AAP certificate within 180 days of hire, or have a master’s degree, be rostered with OPR and be working through the required supervised hours, and clinical staff need supervision from a qualified licensed professional at least twice a month. AAP and ADC staff generally cost less than a fully licensed LADC, which keeps payroll more manageable while they build toward their own license. Pairing one RN with LPNs for medical coverage rather than staffing every shift with a registered nurse trims nursing costs the same way. The actual staffing matrix and cost estimate come together once program model and census are confirmed.

How to Submit Your Therapeutic Community Residence Application

Contact DAIL’s Division of Licensing and Protection at (802) 241-0480 or the Survey and Certification unit at AHS.DAILDLPSurveyandCertification@vermont.gov to request the current application packet. The form asks for fire safety approval from the Department of Public Safety, proof of local zoning compliance, a Department of Environmental Conservation letter on water and sewage, floor plans, proof of workers’ compensation coverage, and, for a first application, three reference letters. The licensee also attests to having “sufficient cash or established credit” to run the home. Mail the completed application to DLP, HC 2 South, 280 State Drive, Waterbury, VT 05671-2306. Separately, contact DSU at (802) 651-1550 or the Vermont Department of Health, 280 State Drive, Waterbury, VT 05671-8340, to begin the SUD program certification process. TCR renewal applications are due 45 days before the current license expires.

What Delays Vermont Residential SUD Projects

Three mistakes account for most of the lost time on these projects. The most common delay is treating DAIL licensure and DSU certification as one process instead of two, which leaves a facility licensed to operate the residence but not yet certified to receive Department of Health funding. The second is discovering a Certificate of Need obligation after construction has already started. The third is a fire safety inspection scheduled too late in the buildout to keep the DAIL survey on track.

Frequently Asked Questions

Sequencing DAIL licensure and DSU certification for a Vermont residential program? Reach out here.

Sources

• 33 V.S.A. § 7102, definitions (mirror of official text): Definitions (checked October 7, 2026)
• 33 V.S.A. § 7103: License (checked October 7, 2026)
• Code Vt. R. 13-110-012 (mirror of official text): Licensing and Operating Regulations for Therapeutic Community Residences (checked October 7, 2026)
• DLP survey report citing the TCR regulations effective 3/1/22: Valley Vista Vergennes survey (checked October 7, 2026)
• DAIL proposed TCR rule filing: Proposed Rule Filing (checked October 7, 2026)
• Legislative Committee on Administrative Rules, minutes of January 30, 2025: LCAR minutes (24-P35) (checked October 7, 2026)
• DLP: License Application / Reapplication form (checked October 7, 2026)
• DLP: Survey Statements and contact page (checked October 7, 2026)
• Vermont Department of Health: Substance Use Disorder Treatment Certification Rule (checked October 7, 2026)
• Vermont Department of Health, DSU: Treatment Provider Certification (checked October 7, 2026)
• Vermont Department of Health, DSU: Preferred Provider Substance Use Disorder Treatment Standards (checked October 7, 2026)
• CARF International: ASAM Level of Care Certification (checked October 7, 2026)
• American Society of Addiction Medicine: Level of Care Certification (checked October 7, 2026)
• Vermont Department of Health: Hospital Licensing Rule (checked October 7, 2026)
• Green Mountain Care Board: Certificate of Need (checked October 7, 2026)
• Act 15 of 2025 (H.96), as enacted: CON monetary thresholds (checked October 7, 2026)
• 18 V.S.A. § 9435 (mirror of official text): Exclusions (checked October 7, 2026)
• Green Mountain Care Board: Emergency CON decision, Integrative Life Network (May 15, 2023) (checked October 7, 2026)
• Green Mountain Care Board: BAART Bennington OTP Hub exemption (February 20, 2024) (checked October 7, 2026)
• DEA Diversion Control Division: Dear Registrant letter, January 12, 2023 (checked October 7, 2026)
• Vermont Department of Health: Rules Governing Medications for Opioid Use Disorder (checked October 7, 2026)
• 42 CFR 8.11: Opioid treatment program certification (checked October 7, 2026)
• Vermont Blueprint for Health: Hub and Spoke (checked October 7, 2026)
• Office of Professional Regulation: Alcohol and Drug Abuse Counselors (checked October 7, 2026)
• 26 V.S.A. § 3236: Licensed alcohol and drug abuse counselor; eligibility (checked October 7, 2026)
• Office of Professional Regulation: AAP, ADC and LADC application instructions (checked October 7, 2026)
• CARF International: Find a Provider (ASAM Level of Care certification filter) (checked October 7, 2026)
• 18 V.S.A. § 9434: Certificate of need monetary thresholds (checked October 7, 2026)
• 18 V.S.A. chapter 221, subchapter 5: Health Facility Planning, §§ 9431 to 9446 (checked October 7, 2026)
• 21 CFR 1308.13(c)(7) (Cornell LII mirror): Ketamine as a Schedule III substance (checked October 9, 2026)
• 21 CFR 1301.12 (Cornell LII mirror): Separate DEA registration for each location (checked October 9, 2026)
• FDA: SPRAVATO prescribing information and Medication Guide, revised 09/2026 (checked October 9, 2026)
• Vermont Prescription Monitoring System rule, Code Vt. R. 13-140-069 (Cornell LII mirror): Reporting exemptions and query triggers (checked October 9, 2026)
• 26 V.S.A. § 1613: APRN transition to practice (checked October 9, 2026)
• 11 V.S.A. chapter 3: Incorporation of Professional Persons (checked October 9, 2026)
• 18 U.S.C. § 220 (Cornell LII mirror): Illegal remunerations for referrals to recovery homes, clinical treatment facilities, and laboratories (checked October 9, 2026)
• Act 133 of 2026 (H.583): Act as enacted and bill status (checked October 9, 2026)